Will Rosellini is the President of CytoImmune Therapeutics, a clinical stage biotechnology company. Previously, he was Chief Executive Officer of Perimeter Medical and, prior to that, Chief Executive Officer of Nexeon Medsystems, a medical device manufacturing company that went public in 2017.
Before that he founded, raised US$16 million across A/B rounds and led Lexington Technology Group, a database company commercialising an electronic health record (EHR) database solution. Before that he founded Sarif Biomedical, a stereotactic cancer microsurgery with IP spun-out of Medtronic. Rosellini completed two acquisitions to form Telemend Medical, Inc. a clinical engineering services company. Rosellini was also Chief Executive Officer at Microtransponder, an implantable neurostimulation developer with solutions for stroke rehabilitation.
He is a former minor league baseball pitcher with the Diamondbacks of the Arizona League, holds a JD, MBA, MS of Accounting, MS of Computational Biology, MS of Neuroscience and MS of Regulatory Science.